RENAY SMITH: Open Payments
NPI 1053977538 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,381 in 35 payments from 21 companies in 2025. Trend: 2023 $891 · 2024 $1,360 · 2025 $1,381
Food & beverage: $1,381
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $352 |
| Janssen Biotech, Inc. | 8 | $337 |
| JAZZ PHARMACEUTICALS INC. | 1 | $115 |
| Lilly USA, LLC | 1 | $90 |
| Legend Biotech USA Inc. | 3 | $70 |
| Caris MPI, Inc. | 1 | $59 |
| TerSera Therapeutics LLC | 2 | $52 |
| Genentech USA, Inc. | 1 | $32 |
| TMS NeuroHealth Centers Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $30 |
Products named: RYBREVANT, ZEPZELCA, CARVYKTI, MI CANCER SEEK, Zoladex, Tecentriq Hybreza, TMS NeuroHealth Centers Inc., ELAHERE.
Industry payments across FL — which companies pay providers there.
